The weight-loss drug Ozempic, popularized in the U.S. by celebrities, is being eyed with concern in the U.K. due to its off-label use and potential side effects. The surge in Ozempic’s popularity in the U.S. has led to shortages and raised concerns about its off-label use for weight loss. The U.S. FDA has stated that any use of Ozempic outside of diabetes treatment would be considered ‘off-label’ use, a situation that could potentially replicate in the U.K.